Upgrade to SI Premium - Free Trial

BioNano Genomics, Inc. (BNGO)

1.13 -0.05 (4.24%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/29/26)

Latest Headlines

Form SCHEDULE 13G Bionano Genomics, Inc. Filed by: HIRSCHMAN ORIN October 19, 2026 2:27 PM - SEC Filing Bionano Laboratories Announces Expansion of Diagnostic Testing Based on Optical Genome Mapping for Hematologic Malignancies September 23, 2026 9:00 AM - StreetInsider Three studies back Bionano's optical genome mapping in blood cancers September 14, 2026 9:01 AM - StreetInsider Bionano Announces Three New Peer-Reviewed Studies Demonstrate Clinical Value of Bionano's Optical Genome Mapping Across Myelodysplastic Syndromes and Acute Myeloid Leukemia September 14, 2026 9:00 AM - Globe NewsWire Bionano Announces Three New Peer-Reviewed Studies Demonstrate Clinical Value of Bionano's Optical Genome Mapping Across Myelodysplastic Syndromes and Acute Myeloid Leukemia September 14, 2026 9:00 AM - StreetInsider Form 8-K Bionano Genomics, Inc. For: Sep 14 September 14, 2026 8:31 AM - SEC Filing MolDX proposes Medicare coverage for genome-wide hematologic testing September 10, 2026 9:02 AM - StreetInsider Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms September 10, 2026 9:00 AM - StreetInsider Bionano Laboratories Announces New York State Department of Health Approval of Lab Developed Tests Based on Optical Genome Mapping September 8, 2026 9:00 AM - StreetInsider Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference August 24, 2026 8:00 AM - StreetInsider Form 4 Bionano Genomics, Inc. For: Aug 21 Filed by: Luderer Albert August 21, 2026 4:31 PM - SEC Filing Form SCHEDULE 13G/A Bionano Genomics, Inc. Filed by: CVI Investments, Inc. August 14, 2026 2:42 PM - SEC Filing Form 10-Q Bionano Genomics, Inc. For: Jun 30 August 10, 2026 4:11 PM - SEC Filing Form 8-K Bionano Genomics, Inc. For: Aug 10 August 10, 2026 4:05 PM - SEC Filing Bionano Reports Second Quarter 2026 Results and Provides a Business Update August 10, 2026 4:05 PM - StreetInsider Form 4 Bionano Genomics, Inc. For: Aug 03 Filed by: Adamchak Mark August 5, 2026 5:28 PM - SEC Filing Form 4 Bionano Genomics, Inc. For: Aug 03 Filed by: Dixon Jonathan V. August 5, 2026 5:28 PM - SEC Filing Form 4 Bionano Genomics, Inc. For: Aug 03 Filed by: OLDAKOWSKI MARK August 5, 2026 5:27 PM - SEC Filing Form 4 Bionano Genomics, Inc. For: Aug 03 Filed by: Hastie Alex Reid August 5, 2026 5:27 PM - SEC Filing Form 3 Bionano Genomics, Inc. For: Aug 03 Filed by: Hastie Alex Reid August 5, 2026 4:00 PM - SEC Filing Form 3 Bionano Genomics, Inc. For: Aug 03 Filed by: Adamchak Mark August 5, 2026 4:00 PM - SEC Filing Form 3 Bionano Genomics, Inc. For: Aug 03 Filed by: Dixon Jonathan V. August 5, 2026 4:00 PM - SEC Filing Form 3 Bionano Genomics, Inc. For: Aug 03 Filed by: OLDAKOWSKI MARK August 5, 2026 4:00 PM - SEC Filing Form 3 Bionano Genomics, Inc. For: Jul 20 Filed by: Hastie Alex Reid July 30, 2026 4:43 PM - SEC Filing Bionano to Report Second Quarter 2026 Financial Results and Host a Conference Call Webcast on August 10, 2026 July 27, 2026 4:05 PM - StreetInsider Full Article List